ME Prakiraan wutah bathi resik saben saham kanggo taun ngarep 23andMe Holding Co

23andMe Inc. - logo grafis emiten ME

Management crises and conflicts with leadership are weighing on quotes, while the projected net profit growth for 23andMe Holding Co. (ME) demonstrates a level of 0.00, capturing current expectations. Diversification through the development of DNA-data-based drugs mitigates risks, yet the mass exodus of leading bioinformaticians and staff reductions threaten the business's survival. This chart helps track the institutional development trends of 23andMe Holding Co. (ME).

ME: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep 23andMe Inc. 04.07.2022 - 05.04.2025

Rincian metrik lan analitis perusahaan 23andMe Inc. (ME)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
Pambiji fundamental perusahaan:23andMe Holding Co., ME
Produk dadi 23andMe Holding Co

Investors must evaluate the competitiveness of 23andMe Holding Co. (ME) through the lens of ESG standard implementation efficiency and genetic data protection. This forward-looking earnings per share growth forecast reflects the consensus estimate of future profitability, enabling a timely identification of business model corrections and preventing the purchase of an overvalued asset amid shifting macroeconomic lags.

Analisis pesaing 23andMe Holding Co.

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|XGN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDxHealth Inc. - Proyeksi tambahing bathi saben saham ing taun ngarep|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Prenetics Global Limited - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep Ainos Corp (AIMD)|Prakiraan wutah bathi kanggo taun ngarep CODX (codiagnostics.com)|Heart Test Laboratories - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Biomerica Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardio Diagnostics Holdings|ONCO (Onconetix Corporation) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Virax Biolabs Group Ltd - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep bluejaydx.com|Prakiraan wutah bathi resik saben saham ing taun ngarep Aspira Women's Health AWH|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Accelerate Diagnostics, Inc (AXDX)|centogene.com - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ENZ (Enzo Biochem)|FRES - Prakiraan wutah bathi saben saham kanggo taun ngarep|Genetic Technologies Ltd - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep